SWAV(Delisted)
ShockWave Medical·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
EPS Beats Expectation
Bearish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SWAV
Shockwave Medical, Inc.
A pioneer in the development of Intravascular Lithotripsy to treat severely calcified cardiovascular disease
5403 Betsy Ross Drive, Santa Clara, California 95054
--
Founded on June 17, 2009, ShockWave Medical, Inc., is a medical device company focused on developing and commercializing products to transform the treatment of calcified cardiovascular disease. Their goal is to establish a new standard for medical devices to treat atherosclerotic cardiovascular disease through their differentiated and proprietary local delivery of acoustic pressure waves for the treatment of calcified plaques, which they call endovascular lithotripsy (" IVL ").
Company Financials
EPS
SWAV has released its 2024 Q1 earnings. EPS was reported at 1.44, versus the expected 0.99, beating expectations. The chart below visualizes how SWAV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SWAV has released its 2024 Q1 earnings report, with revenue of 218.81M, reflecting a YoY change of 35.85%, and net profit of 55.35M, showing a YoY change of 41.46%. The Sankey diagram below clearly presents SWAV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
